Covid 19 Research using Clinical Trials (Home Page)
Report for D001924: Brain Concussion NIH
(Synonyms: Brain Concu, Brain Concussion)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (4)
|
Name (Synonyms) |
Correlation |
drug1754 | Pacing + mindfulness Wiki | 1.00 |
drug2341 | Standard therapy for COVID-19 according to the stablished hospital protocols. Wiki | 1.00 |
drug1006 | Graded exposure therapy Wiki | 1.00 |
drug603 | Colchicine Tablets Wiki | 0.58 |
Correlated MeSH Terms (2)
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
At least 1 in 5 people who sustain a concussion will have persistent symptoms and
difficulties with daily activities. The researchers have identified two unhelpful coping
styles following a concussion - avoidance and endurance. Individuals who engage in avoidance
behavior may benefit from a different type of treatment than those who engage in endurance
behavior. The researchers will evaluate whether assigning individuals to a specific
psychologically-informed treatment tailored to their coping style is practical, acceptable,
and beneficial for their recovery.
NCT03972579 Mild Traumatic Brain Injury Behavioral: Graded exposure therapy Behavioral: Pacing + mindfulness
Primary Outcomes
Measure: World Health Organization Disability Assessment Schedule (WHODAS) 2.0 12-item Time: Initial assessment, past 30 days.
Secondary Outcomes
Measure: Rivermead Postconcussion Symptom Questionnaire Time: initial assessment, past 24 hours.
HPO Nodes